Teladoc Health is a leading telehealth company that provides virtual healthcare services, connecting patients with a wide range of healthcare professionals through digital platforms
The company offers various services, including remote consultations, mental health support, chronic condition management, and preventive care. By leveraging technology, Teladoc facilitates access to healthcare for individuals regardless of their location, aiming to improve health outcomes and enhance the patient experience. Their comprehensive solutions cater to both individual consumers and large employers, helping to make healthcare more accessible and efficient.
PURCHASE, NY, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSETDOC), the global leader in virtual care, announced that it will release fourth quarter 2024 results on Wednesday, February 26, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how online marketplace stocks fared in Q3, starting with Teladoc (NYSETDOC).
Discover the top stock picks for today's risk-on market, driven by light PPI data and anticipation of CPI. This article provides a macro review, detailed analyses of key trades, and swing trade opportunities, including KTOS, NBIS, ROOT, and more.
PURCHASE, NY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSETDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13, 2025, at 4:30 p.m. PT (7:30 p.m. ET). A live audio webcast and replay of the presentation will be available at https://ir.teladochealth.com/news-and-events/events-and-presentations.
Since June 2024, Teladoc has been in a holding pattern, posting a small return of 0.6% while floating around $9.38. The stock also fell short of the S&P 500’s 8.8% gain during that period.
Discover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate.
